WP
ACET icon

Woodline Partners’s Adicet Bio ACET Stock Holding History

Woodline Partners’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-313,124
Closed -$2.13M – 1014
2026
Q1 		$2.13M Sell
313,124
-311,876
-50% -$2.33M 0.01% 800
2025
Q4 		$5.26M Buy
+625,000
New +$6.91M 0.02% 616
2024
Q3 		– Sell
-30,381
Closed -$588K – 588
2024
Q2 		$588K Sell
30,381
-15,562
-34% -$417K 0.01% 492
2024
Q1 		$1.73M Buy
+45,943
New +$1.9M 0.02% 434
2022
Q2 		– Sell
-12,282
Closed -$3.92M – 794
2022
Q1 		$3.92M Buy
+12,282
New +$2.82M 0.06% 272

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Woodline Partners's ACET Position: Q2 2026 in Review

Woodline Partners sold out of Adicet Bio (ACET) in Q2 2026, closing a stake of 313,124 shares — an estimated $2.13M sold.

Woodline Partners first reported a position in ACET in Q1 2022 and held it in 5 quarters. The position peaked at $5.26M in Q4 2025. 56 funds tracked by Wall St. Rank hold ACET as of Q2 2026.

  • Woodline Partners reported no remaining Adicet Bio position as of Q2 2026 after selling out during the quarter.
  • Woodline Partners sold 313,124 Adicet Bio shares in Q2 2026, an estimated $2.13M.
  • Woodline Partners first reported a position in Adicet Bio in Q1 2022 and held it in 5 quarters.
  • Woodline Partners's Adicet Bio position peaked at $5.26M in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.